Dianthus Therapeutics
DNTH
DNTH
90 hedge funds and large institutions have $418M invested in Dianthus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 92 → 90 (-2)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
Holders
90
Holding in Top 10
2
Calls
$739K
Puts
$182K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$7.99M | |
| 3 | +$7.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.81M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$6.59M |
Top Sellers
| 1 | -$7.84M | |
| 2 | -$4.16M | |
| 3 | -$1.68M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.51M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$985K |